About our chairman and CEO


Chairman, & Scientific Director

Chairman, & CEO

As Chairman and CEO of Nanobiosym® and Nanobiosym® Diagnostics, Dr. Goel is focused on delivering new game-changing technologies to address the greatest unmet needs in global health, energy, and the environment.

A Harvard-MIT-trained Physicist-Physician, Dr. Anita Goel is a globally recognized leader in the emerging field of nanobiophysics—a new science at the convergence of physics, nanotechnology, and biomedicine. Nanobiophysics integrates these three fields to reveal new scientific solutions to the world’s most pressing challenges.

Her pioneering contributions to nanotechnology and nanobiophysics have been recognized globally by prestigious honors and awards including multiple awards from US Government agencies such as Defense Advanced Research Projects Agency (DARPA), Department of Defense (DOD), Department of Energy (DOE), Air Force Office of Scientific Research (AFOSR) and US Defense Threat Reduction Agency (DTRA).

She established Nanobiosym® Diagnostics to commercialize the Gene-RADAR® technology platform to empower people worldwide with portable, rapid and accurate information about their own health. Employing the latest advances in nanotechnology, Gene-RADAR® is a fully portable, chip-based diagnostic that can recognize any disease with a genetic fingerprint from a single drop of blood or saliva without the need for lab infrastructure, trained health care personnel, electricity or running water.



Dr. Goel created the Nanobiosym Global Initiative to bring emerging technologies into emerging economies by forming innovative public-private partnerships with governments, NGOs, industries, academia and global thought leaders across the world. Dr. Goel believes that the most pressing global challenges in water, food security, energy and the environment necessitate a highly collaborative effort between governments, non-profit institutions and the private sector. She has a special interest in bringing disruptive technologies like Gene-RADAR® to address the critical unmet needs of people at the bottom of the pyramid in both the developed and developing world.

Dr. Goel has been invited by Senator John Kerry to give expert testimony before the US Senate Subcommittee on Science, Technology and Innovation to support the reauthorization of the $1.5 billion U.S. National Nanotechnology Initiative. Dr. Goel was invited to advise President Obama’s Strategy for American Innovation for the President’s Council of Advisors on Science and Technology (PCAST) and help build the roadmap for harnessing nanotechnology to stimulate the US economy. Dr. Goel was invited to chair a roundtable on “Using Science and Technology as a Tool for International Diplomacy” at the 2009 Science and Technology in Society Forum in Kyoto, Japan. While at Stanford, she envisioned building new hi-tech bridges between developed and developing world economies and founded and chaired an international conference and think tank (SETU—Sanskrit for ‘bridge’), comprised of world leaders from academic, business, socio-political, and humanitarian arenas. Dr. Goel has been a featured keynote speaker at many major international conferences, symposia, and university colloquia and often gives Guest Faculty Lectures at Harvard and MIT. She was recently a featured speaker at the 2010 TEDMED Conference, 2010 TedxAmsterdam and 2010 INK Conference in India.

Dr. Goel was named as one of the world’s “Top 35 Science and Technology Innovators under the age of 35” by MIT Technology Review. Among other awards and prizes, she received the “Global Indus Technovator Award” from MIT, an honor recognizing the contributions of top leaders working at the forefront of science, technology, and entrepreneurship. She holds a PhD in Physics from Harvard University, an MD from the Harvard-MIT Joint Division of Health Sciences & Technology (HST), and a BS in Physics with Honors and Distinction from Stanford University.

Dr. Goel has a deep passion for fundamental science, especially elucidating the physics of living systems at the nanoscale. Her work in applied science harnesses these fundamental insights to develop next-generation nanotechnology platforms like Gene-RADAR® for portable disease detection and nanosystems for novel energy harvesting and biocomputing applications. Some of her recent publications include “Molecular Evolution: a role for quantum mechanics in the dynamics of molecular machines that read DNA,” in the book Quantum Aspects of Life and “Tuning DNA Strings: Precision Control of Nanomotors” in Scientific American, India edition and “Harnessing Biological Motors to Engineer Systems for Nanoscale Transport and Assembly” in Nature Nanotechnology.

Dr. Goel is a Member of the Board of Overseers of the Boston Museum of Science and a Charter Member of TiE (The Indus Entrepreneurs, a global organization of successful entrepreneurs engaged in the cycle of wealth creation and giving back to society). Dr. Goel is also a Fellow of the World Technology Network, a Fellow-at-Large of the Santa Fe Institute, an Associate of the Harvard Physics Department and an Adjunct Professor of the BEYOND Institute for Fundamental Concepts in Science at Arizona State University. She also serves on the National Board of the Museum of Science and Industry, the International Advisory Board of the Victoria Institute of Science and Technology, Founding Member. Global Council for the (CHI) Center for Health care Innovation, and on the Nanotechnology Advisory Board of the Lockheed Martin Corporation.


View Dr. Goel’s Academic Profile



The confidence to boldly enter unforeseen markets and transcend boundaries between conventional disciplines.

"There is extraordinary potential we can unlock for nanotechnology in life sciences… As visionaries and innovators such as Dr. Goel work to harness the incredible potential of nanotechnology, the Federal government has a critical role to play."
— Senator John Kerry

"Behind this vision is game-changing technology which can revolutionize healthcare globally. In the face of growing world health crises and transnational epidemics, Dr. Goel and Nanobiosym are redefining the rules in the battle to diagnose disease and save lives."
— Alfred Ford, Director of Ford Motor Company Fund and Josephine Ford Cancer Center

"Nanotechnology has the potential to revolutionize the way we tackle key issues facing the world today, and Nanobiosym is working at the forefront of this revolution. Dr. Goel has forged a bold model for driving technological innovation and commercialization, while maximizing global humanitarian impact."
— Mr. Ratan Tata, Chairman of TATA Group

"Nanobiosym’s technology platform is truly game-changing and has the potential to radically redefine the rules of medical diagnosis. Dr Goel’s approach to medicine through the lens of physics and nanotechnology could bring about fundamental paradigm shifts in modern medicine, possibly even quantum leaps in how we diagnose and heal diseases."
— John Abele, Co-founder of Boston Scientific

"DARPA is an agency that funds extremely innovative high-risk, high-reward research to accelerate the realization of disruptive technologies, and the capabilities developed by Dr. Goel at Nanobiosym could potentially revolutionize the fields of pathogen sensing/detection, energy harvesting, and bio-molecular computation…If this indeed is the century of biology and biotechnology, as many leading scientific thinkers are predicting, her work is going to provide one of the key underpinnings for the coming revolution."
- Dr. Krishnan, Former DARPA Program Manager

"Dr. Goel is doing some of the most exciting work in biophysics and nano-biotechnology today; someone who I predict will fundamentally be carving out the landscape of this field in the years to come."
— Dr. Baltes, Professor of Physics, ETH-Zurich; Co-founder of SENSIRION